Christy Jones
PER
Jones Christy Jones
In her closing argument, Christy Jones, Merck's lead lawyer, told jurors that Merck had properly researched Vioxx's potential heart risks. After a clinical trial in 2001 showed that the number of heart attacks among patients taking Vioxx was five times that among those taking naproxen, an older pain reliever, Merck disclosed the trial's findings to both doctors and the Food and Drug Administration, Ms. Jones said. She also argued that Thomas Cona had not proved that he took Vioxx and that his heart attack had been so mild that he had not suffered any permanent damage from it.